Are there differences among angiotensin receptor blockers?

Area of Science:

• Cardiovascular Medicine
• Pharmacology

Background:

• Therapeutic drug classes are often assumed to have similar efficacies.
• Head-to-head comparisons are rare, limiting differentiation between drugs within a class.

Purpose of the Study:

• To compare the antihypertensive efficacy of irbesartan and losartan.
• To determine if angiotensin receptor blockers (ARBs) have similar efficacies.

Main Methods:

• Two randomized clinical trials were conducted.
• One trial used a fixed-dose protocol, and the other used a titration protocol.

Main Results:

• Irbesartan demonstrated a greater reduction in blood pressure compared to losartan.
• The response rate was higher in patients treated with irbesartan.
• Significant differences in efficacy were observed between these two ARBs.

Conclusions:

• Irbesartan is a more potent antihypertensive agent than losartan.
• Angiotensin receptor blockers exhibit more differences than similarities in their pharmacologic profiles and clinical effects.